Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock
The price of the company's popular GLP-1 drugs could come down by as much as 50% next year.
Source: www.fool.com
The price of the company's popular GLP-1 drugs could come down by as much as 50% next year.